Manuela Joore
banner
manuelajoore.bsky.social
Manuela Joore
@manuelajoore.bsky.social

Health Technology Assessment by day, democracy lover by always. Cats, wine, books, and plants

Economics 58%
Public Health 12%

Reposted by Manuela Joore

A team of #REPO4EU researchers from @maastrichtumc.bsky.social have developed a new tool to make decision models more accessible in early-stage or data-limited healthcare research.

But how will it benefit #DrugRepurposing researchers? Read the full story to find out 👉 repo4.eu/2025/08/26/r...

Reposted by Manuela Joore

#RExPO25 Speakers | Session 4:

🟣 Ranjita Shegokar (DiHeSys)

🟣 Eduardo Díaz (FABRX AI)

🟣 Elisabetta Vaudano (‪@ihieurope.bsky.social‬)

🟣 Lee Lancashire (EveryCure)

🟣 Merel Kimman (Maastricht UMC+)

Check the full conference agenda ⤵️
repo4.eu/rexpo25/agen...

🇪🇺 #EUfunded #DrugRepurposing

Nieuwe behandeling? Alleen nog vergoeden als die klimaat en zorgpersoneel spaart
The Editorial Boards of leading health economics journals are issuing a Joint Statement of Principles on Editorial Independence. In these troubled times some scholars worry their work might suffer ideological attack. We reaffirm our commitment to unfettered scholarship. Please repost.

Reposted by Manuela Joore

Big Pharma is using Trump’s tariff threat to hold Europe to ransom.

Our health should not be in the hands of these profiteers. We need a better way of making medicines.

Pleased to be in Politico with Peter Maybarduk of @publiccitizen.bsky.social 👇

www.politico.eu/article/phar...
Big Pharma is using tariffs to hold Europe to ransom
We can have a world where everyone has access to the medicines they need. But both Trump and pharma companies will push us in the opposite direction.
www.politico.eu

Our latest paper: adaptable framework for cost-analyses of proton and photon therapy.

Huge thanks to Bradley Sugden and the team -Willem Witlox, Bram Ramaekers, Djoya Hattu, Boy Vluggen, Judith van Loon, Maria Jacobs, Dirk De Ruysscher- for making it happen! www.thegreenjournal.com/article/S016...
Adaptable framework for cost-analyses in radiotherapy: Application to the cost of proton versus photon therapy for lung cancer in The Netherlands
Around fifty percent of cancer treatment plans in The Netherlands involve radiotherapy [1], with external beam radiotherapy the most common modality. For lung cancer, external beam radiotherapy is adm...
www.thegreenjournal.com

Reposted by Manuela Joore

How can we ensure patients get safe, equitable access to repurposed drugs? 💊

Top EU policymakers, regulators, patient advocates & industry leaders addressed this question at our first policy event, supported by @ec.europa.eu

Check out the compilation video! 🎥
youtu.be/mm_e-1m0Lpg?...
Building sustainable models for drug repurposing: Highlights from REPO4EU's Policy Event
YouTube video by REPO4EU
youtu.be

Reposted by Manuela Joore

Update on the Kootenai Town Hall meeting where they dragged someone out for speaking their mind. The Sheriff, which was the first one to grab at her denies he had anything to do with it.
The men that actually dragged her off work for Lear Asset Mngmt whose license has now been suspected on town.
Was Vance’s speech just now in Munich the ugliest example of gaslighting in recent times?? Not Russia, not extreme right, but European moderators who fight “desinformation” are worst enemies of democracy. We’ve arrived in a nightmare mirror world.
Censor CDC scientists and ask them to withdraw papers from medical journals?

This is not how it works, Mr President.

Our response @bmj.com on the Trump Executive Order and his "forbidden words"

www.bmj.com/content/388/...

Thank you for your invaluable contributions @akesselheim.bsky.social and team @portalresearch.org It is a great pleasure to work with you all @repo4eu.bsky.social @sabine-e-grimm.bsky.social @araymakers.bsky.social

Reposted by Manuela Joore

Also out this week a review of new EU pharma policies and their potential impact on repurposed drugs with the excellent Mirre Scholte and Manuela Joore who are collaborating with @portalresearch.org on the REPO4EU project: pubmed.ncbi.nlm.nih.gov/39756647/
Revising EU pharmaceutical legislation: will it foster drug repurposing? - PubMed
Repurposing off-patent drugs can be a potential source of low-cost treatments for patients with unmet medical needs. Here, we review the proposed new European Union (EU) pharmaceutical legislation in ...
pubmed.ncbi.nlm.nih.gov
Sometimes the combination of arrogance and ignorance is breathtaking. Yes, US health care has high admin costs; that's because it relies so much on private insurers. Govt-run health insurance has much lower overhead

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore

Reposted by Manuela Joore